A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer diseaseStephen Salloway, Michael Grundman, Reisa A. Sperling et al.|Neurology|2009Cited by 739
Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer DiseaseStephen Salloway, Karen Smirnakis, Ying Tian et al.|JAMA Neurology|2021Cited by 590
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysisReisa A. Sperling, Michael Grundman, Stephen Salloway et al.|The Lancet Neurology|2012Cited by 510
MR Imaging Features of Amyloid-Related Imaging AbnormalitiesJerome Barakos, Michael Grundman, Reisa A. Sperling et al.|American Journal of Neuroradiology|2013Cited by 111